Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

TRVI — Trevi Therapeutics, Inc. SEC Filings | FilingIndex

TRVINasdaq

Trevi Therapeutics, Inc.

Pharmaceutical Preparations · DE · CIK 1563880

Develops and commercializes Haduvio for chronic cough in adults with lung diseases

+ Watch View on EDGAR ↗

$2.02B

Market cap

$18.65

Last close

+0.1%

1D

+7.3%

5D

3.1M

Volume

Price · last 40 sessions+29.7%

May 4L $13.24 · H $18.65Jun 30

152

Total filings

Jun 4, 2026

Last filing

12/31

Fiscal year end

All 8-K · 79 10-Q · 22 SC 13G · 12 424B5 · 8 DEFA14A · 8 10-K · 7 DEF 14A · 7 S-1/A · 3

SC 13GTREVI SC 13GAFeb 15, 2023 SC 13GSC 13GFeb 10, 2023 SC 13GSC 13GOct 7, 2022 SC 13GSC 13GApr 21, 2022 SC 13GSC 13GApr 21, 2022 SC 13G

Similar companies

Comparable business profile · signals at a glance

AVLNAvalyn Pharma Inc.$1.3B+6.2%RNTXRein Therapeutics, Inc.$81.9M0.0%CTNMContineum Therapeutics, Inc.$444.2M+9.3%TBPHTheravance Biopharma, Inc.$857.8M-0.3%GYREGYRE THERAPEUTICS, INC.

SC 13G

Apr 18, 2022

SC 13GMAI 13GApr 8, 2022

SC 13GSC 13GMar 9, 2022

SC 13GSC 13GMar 9, 2022

SC 13GSC 13GFeb 14, 2022

SC 13GACQUISITION OF BENEFICIAL OWNERSHIPFeb 13, 2020

SC 13GSC 13GJan 31, 2020

$575.4M

+2.2%

DWTXDogwood Therapeutics, Inc.$51.8M-9.6%